Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // December 9th, 2010 // 8:00 am
Hello, everyone. Another sunny - and cold - day here on the Pharmalot corporate campus, where we are, as usual, hustling the short people off to this or that school house. To keep warm, we are brewing the mandatory cup of stimulation and searching for some hot news. Meanwhile, here are a few items of interest. We hope your days goes well. Do stay in touch…
Pfizer Names Simmons As Head Of Emerging Markets (Bloomberg News)
Teva’s MS Drug Meets Primary Endpoint (Reuters)
Nigeria Denies Blame For Delay In Pfizer Payments (AllAfrica)
India Will Not Compromise Local Pharma In EU Pact (LiveMint)
Roche Advances Schizophrenia And MS Drugs (Reuters)
Daily Aspirin Slashes Cancer Risk: Study (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Aspirin, Cancer, David Simmons, Emerging Markets, European Union, Free Trade, India, MS, Multiple Sclerosis, Pfizer, Roche, Schizophrenia, Teva Pharmaceuticals